These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 11283668)

  • 21. Hypertension-enhanced monocyte adhesion in experimental atherosclerosis.
    Tropea BI; Huie P; Cooke JP; Tsao PS; Sibley RK; Zarins CK
    J Vasc Surg; 1996 Apr; 23(4):596-605. PubMed ID: 8627894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis.
    Clinton SK; Underwood R; Hayes L; Sherman ML; Kufe DW; Libby P
    Am J Pathol; 1992 Feb; 140(2):301-16. PubMed ID: 1739124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of vascular endothelial growth factor-mediated neointima progression with angiostatin or paclitaxel.
    Celletti FL; Waugh JM; Amabile PG; Kao EY; Boroumand S; Dake MD
    J Vasc Interv Radiol; 2002 Jul; 13(7):703-7. PubMed ID: 12119329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of angiogenesis by smooth muscle cell-derived factor: possible role in neovascularization in atherosclerotic plaque.
    Kuzuya M; Satake S; Esaki T; Yamada K; Hayashi T; Naito M; Asai K; Iguchi A
    J Cell Physiol; 1995 Sep; 164(3):658-67. PubMed ID: 7544360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Local monocyte chemoattractant protein-1 therapy increases collateral artery formation in apolipoprotein E-deficient mice but induces systemic monocytic CD11b expression, neointimal formation, and plaque progression.
    van Royen N; Hoefer I; Böttinger M; Hua J; Grundmann S; Voskuil M; Bode C; Schaper W; Buschmann I; Piek JJ
    Circ Res; 2003 Feb; 92(2):218-25. PubMed ID: 12574150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth.
    Luttun A; Lutgens E; Manderveld A; Maris K; Collen D; Carmeliet P; Moons L
    Circulation; 2004 Mar; 109(11):1408-14. PubMed ID: 14993123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of recombinant apolipoprotein A-I(Milano) on aortic atherosclerosis in apolipoprotein E-deficient mice.
    Shah PK; Nilsson J; Kaul S; Fishbein MC; Ageland H; Hamsten A; Johansson J; Karpe F; Cercek B
    Circulation; 1998 Mar; 97(8):780-5. PubMed ID: 9498542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aortic atherosclerotic plaque injury in apolipoprotein E deficient mice.
    Reddick RL; Zhang SH; Maeda N
    Atherosclerosis; 1998 Oct; 140(2):297-305. PubMed ID: 9862272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of vascular endothelial and platelet-derived growth factor receptor inhibitors on long-term cultures from normal human bone marrow.
    Dührsen U; Martinez T; Vohwinkel G; Ergün S; Sun L; McMahon G; Dürig J; Hossfeld DK; Fiedler W
    Growth Factors; 2001; 19(1):1-17. PubMed ID: 11678206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dissection of monocyte and endothelial activities by using VEGF-receptor specific ligands.
    Clauss M; Pipp F; Issbrücker K; Weich H; Heil M; Schaper W
    Adv Exp Med Biol; 2003; 522():75-82. PubMed ID: 12674212
    [No Abstract]   [Full Text] [Related]  

  • 31. A specific 15-lipoxygenase inhibitor limits the progression and monocyte-macrophage enrichment of hypercholesterolemia-induced atherosclerosis in the rabbit.
    Bocan TM; Rosebury WS; Mueller SB; Kuchera S; Welch K; Daugherty A; Cornicelli JA
    Atherosclerosis; 1998 Feb; 136(2):203-16. PubMed ID: 9543090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intracavernosal injections of vascular endothelial growth factor protects endothelial dependent corpora cavernosal smooth muscle relaxation in the hypercholesterolemic rabbit: a preliminary study.
    Henry GD; Byrne R; Hunyh TT; Abraham V; Annex BH; Hagen PO; Donatucci CF
    Int J Impot Res; 2000 Dec; 12(6):334-9. PubMed ID: 11416837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Susceptibility to atherosclerosis in mice expressing exclusively apolipoprotein B48 or apolipoprotein B100.
    Véniant MM; Pierotti V; Newland D; Cham CM; Sanan DA; Walzem RL; Young SG
    J Clin Invest; 1997 Jul; 100(1):180-8. PubMed ID: 9202070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Citreoviridin Enhances Atherogenesis in Hypercholesterolemic ApoE-Deficient Mice via Upregulating Inflammation and Endothelial Dysfunction.
    Hou HF; Yuan N; Guo Q; Sun T; Li C; Liu JB; Li QW; Jiang BF
    PLoS One; 2015; 10(5):e0125956. PubMed ID: 25933220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular endothelial growth factor effects on nuclear factor-kappaB activation in hematopoietic progenitor cells.
    Dikov MM; Oyama T; Cheng P; Takahashi T; Takahashi K; Sepetavec T; Edwards B; Adachi Y; Nadaf S; Daniel T; Gabrilovich DI; Carbone DP
    Cancer Res; 2001 Mar; 61(5):2015-21. PubMed ID: 11280761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primate.
    Tolentino MJ; McLeod DS; Taomoto M; Otsuji T; Adamis AP; Lutty GA
    Am J Ophthalmol; 2002 Mar; 133(3):373-85. PubMed ID: 11860975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age-dependent impairment of reendothelialization after arterial injury: role of vascular endothelial growth factor.
    Gennaro G; Ménard C; Michaud SE; Rivard A
    Circulation; 2003 Jan; 107(2):230-3. PubMed ID: 12538420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapamycin attenuates atherosclerotic plaque progression in apolipoprotein E knockout mice: inhibitory effect on monocyte chemotaxis.
    Pakala R; Stabile E; Jang GJ; Clavijo L; Waksman R
    J Cardiovasc Pharmacol; 2005 Oct; 46(4):481-6. PubMed ID: 16160601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The in vivo bioactivity of vascular endothelial growth factor/vascular permeability factor is independent of N-linked glycosylation.
    Walter DH; Hink U; Asahara T; Van Belle E; Horowitz J; Tsurumi Y; Vandlen R; Heinsohn H; Keyt B; Ferrara N; Symes JF; Isner JM
    Lab Invest; 1996 Feb; 74(2):546-56. PubMed ID: 8780172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective inactivation of p27(Kip1) in hematopoietic progenitor cells increases neointimal macrophage proliferation and accelerates atherosclerosis.
    Díez-Juan A; Pérez P; Aracil M; Sancho D; Bernad A; Sánchez-Madrid F; Andrés V
    Blood; 2004 Jan; 103(1):158-61. PubMed ID: 14504088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.